Consensus report: clinical recommendations for the prevention and management of the nocebo effect in biosimilar-treated IBD patients.
Pouillon L
Aliment Pharmacol Ther. 2019 Apr 1;49(9):1181-1187. doi: 10.1111/apt.15223
Caspofungin for primary antifungal prophylaxis after T-cell-replete haploidentical stem cell transplantation with post-transplant cyclophosphamide.
Mariotti J
Eur J Haematol. 2019 Feb 13;102(4):357-367. doi: 10.1111/ejh.13214
Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma.
Spina V
Blood. 2018 Feb 15;131(22):2413-2425. doi: 10.1182/blood-2017-11-812073
Constitutive localization of DR4 in lipid rafts is mandatory for TRAIL-induced apoptosis in B-cell hematologic malignancies.
Marconi M
Cell Death Dis. 2013 Oct 17;4(10):e863. doi: 10.1038/cddis.2013.389
Comparative assessment of telomere length before and after hematopoietic SCT: role of grafted cells in determining post-transplant telomere status.
Ruella M
Bone Marrow Transplant. 2009 Oct 19;45(3):505-12. doi: 10.1038/bmt.2009.297
CD52 antigen expressed by malignant plasma cells can be targeted by alemtuzumab in vivo in NOD/SCID mice.
Carlo-Stella C
Exp Hematol. 34(6):721-7.
Clinical protocol. Immunization of patients with malignant melanoma with autologous CD34(+) cell-derived dendritic cells transduced ex vivo with a recombinant replication-deficient vaccinia vector encoding the human tyrosinase gene: a phase I trial.
Di Nicola M
Hum Gene Ther. 14(14):1347-60.
CD34+ cells mobilized by cyclophosphamide and granulocyte colony-stimulating factor (G-CSF) are functionally different from CD34+ cells mobilized by G-CSF.
Cesana C
Bone Marrow Transplant. 21(6):561-8.
Clonogenic capacity and ex vivo expansion potential of umbilical cord blood progenitor cells are not impaired by cryopreservation.
Almici C
Bone Marrow Transplant. 19(11):1079-84.
Clinical relevance of two in vitro tests based on CFU-GM assay in the study of granulopoietic failure.
Carlo Stella C
Haematologica. 70(6):487-94.